{"log_id": 1010622258696523756, "direction": 0, "words_result_num": 31, "words_result": [{"probability": {"variance": 0.023801, "average": 0.902983, "min": 0.492196}, "location": {"width": 819, "top": 150, "height": 35, "left": 184}, "words": "什行短照多心究,盐酸多柔比星脂质体组和ABV纽每2周给药一次,最多6次。该研"}, {"probability": {"variance": 0.013935, "average": 0.957602, "min": 0.486138}, "location": {"width": 824, "top": 202, "height": 29, "left": 180}, "words": "包括258名至更度卡波氏肉瘤患者(患者统计:男性98%,高加索人75%,平均年龄"}, {"probability": {"variance": 0.017803, "average": 0.933789, "min": 0.436319}, "location": {"width": 811, "top": 249, "height": 34, "left": 179}, "words": "58岁,同竹>90%),用盐酸多柔比星脂质体利ABV治疗的病人数分别为133125例"}, {"probability": {"variance": 0.026733, "average": 0.874467, "min": 0.390291}, "location": {"width": 449, "top": 301, "height": 28, "left": 179}, "words": "和有,大部分病人成为预后不佳人群"}, {"probability": {"variance": 0.020435, "average": 0.934231, "min": 0.35303}, "location": {"width": 778, "top": 350, "height": 35, "left": 227}, "words": "要的边终点指标基丁治疗的反应率(5个标准:完全缓解,临床完全缓解。部分缓"}, {"probability": {"variance": 0.008592, "average": 0.961926, "min": 0.476906}, "location": {"width": 832, "top": 401, "height": 33, "left": 173}, "words": ",稳定,疾病进展),而临床受益是建立在患者的癌性疼痛、与肿瘤相关的全身症状和体"}, {"probability": {"variance": 0.004284, "average": 0.969237, "min": 0.727691}, "location": {"width": 829, "top": 451, "height": 34, "left": 174}, "words": "征、体力状况评分(KPS)和两种生活质量评分(QOL)基础上的评价。一项评价QOL的问卷专"}, {"probability": {"variance": 0.008983, "average": 0.954972, "min": 0.530939}, "location": {"width": 775, "top": 500, "height": 31, "left": 171}, "words": "门针对与艾温病相关的卡波氏肉瘤,其它的评价采用了“药物疗效研究”( Medical OL"}, {"probability": {"variance": 0.009351, "average": 0.964189, "min": 0.416677}, "location": {"width": 831, "top": 550, "height": 31, "left": 171}, "words": "tudy获得的方法,该方法使用了“药物疗效研究“中的与HIV相关的项目,并通过比较"}, {"probability": {"variance": 0.024066, "average": 0.914632, "min": 0.491536}, "location": {"width": 562, "top": 597, "height": 34, "left": 172}, "words": "无量状HIV感染者和带有艾滋病相关综合症病人而得到验证"}, {"probability": {"variance": 0.008367, "average": 0.975464, "min": 0.445096}, "location": {"width": 781, "top": 647, "height": 35, "left": 221}, "words": "治疗终点的完全部分反应率证明了一个有利于盐酸多柔比星脂质体组的显著的统计学"}, {"probability": {"variance": 0.026839, "average": 0.903351, "min": 0.373609}, "location": {"width": 827, "top": 690, "height": 48, "left": 167}, "words": "差异,盐酸多柔比星脂质体组和ABV组的反应率分别为46%和26%两组缓精医"}, {"probability": {"variance": 0.019604, "average": 0.936307, "min": 0.488576}, "location": {"width": 808, "top": 743, "height": 39, "left": 171}, "words": "似(盐酸多柔比早脂质体与ABV组平均缓解持续时间分别为92.5天与8天中位"}, {"probability": {"variance": 0, "average": 0.729093, "min": 0.729093}, "location": {"width": 38, "top": 747, "height": 29, "left": 983}, "words": "爱"}, {"probability": {"variance": 0.035587, "average": 0.897632, "min": 0.380712}, "location": {"width": 866, "top": 793, "height": 34, "left": 168}, "words": "前持续时间分别为90天与92大)2除瘤体大小以外的其他病灶特征(如瘦结十肿"}, {"probability": {"variance": 0.014929, "average": 0.938991, "min": 0.475893}, "location": {"width": 830, "top": 842, "height": 35, "left": 168}, "words": "i利疼的结果表明与基值相比:两组均有所改善。死亡不是其中的一项罐瓷终点,但"}, {"probability": {"variance": 0.011853, "average": 0.948685, "min": 0.574628}, "location": {"width": 566, "top": 892, "height": 30, "left": 167}, "words": "酸多梁比用指质体的中位生存期为160天,ABV为153天"}, {"probability": {"variance": 0.012795, "average": 0.958864, "min": 0.471799}, "location": {"width": 785, "top": 940, "height": 35, "left": 215}, "words": "关于QOL答卷,在九方面中有五个利于盐酸多柔比星脂质体组的统计学的显著差"}, {"probability": {"variance": 0.001888, "average": 0.984365, "min": 0.747683}, "location": {"width": 831, "top": 988, "height": 36, "left": 167}, "words": "异:总健康水平、疼痛、社交功能、体力水平和健康隐患。有关针对与卡波氏肉瘤相关的问"}, {"probability": {"variance": 0.014605, "average": 0.946401, "min": 0.370289}, "location": {"width": 828, "top": 1037, "height": 36, "left": 168}, "words": "卷,在九个方中有四个有利于盐酸多柔比星脂质体组的显著统计学差异:肺功能障碍/疼"}, {"probability": {"variance": 0.049477, "average": 0.878667, "min": 0.352714}, "location": {"width": 458, "top": 1087, "height": 27, "left": 165}, "words": "部肢体动受限,运动受限以及睡眠障碍"}, {"probability": {"variance": 0.006229, "average": 0.966322, "min": 0.670965}, "location": {"width": 786, "top": 1134, "height": 34, "left": 212}, "words": "上所述,这一研究表明盐酸多柔比星脂质体与ABV方案有相同效果,在某些方面优"}, {"probability": {"variance": 0.010141, "average": 0.952061, "min": 0.50143}, "location": {"width": 825, "top": 1182, "height": 33, "left": 167}, "words": "ABV组,如,疾病症状和容颜改善方面。尽管ABV组中没有一个药物是批推用来治疗"}, {"probability": {"variance": 0.026581, "average": 0.906096, "min": 0.37517}, "location": {"width": 833, "top": 1224, "height": 39, "left": 162}, "words": "ADSKS,但这种选择是较合理的,因为,它是目前公认的治疗晚期 AIDKS的效"}, {"probability": {"variance": 0.037272, "average": 0.893781, "min": 0.367701}, "location": {"width": 841, "top": 1298, "height": 71, "left": 207}, "words": "阳性对照究3011设计为盐酸多柔比星脂质体组与BV组(博染长养新碱"}, {"probability": {"variance": 0, "average": 0.97305, "min": 0.97305}, "location": {"width": 28, "top": 1354, "height": 27, "left": 864}, "words": "将"}, {"probability": {"variance": 0.01291, "average": 0.964449, "min": 0.491441}, "location": {"width": 857, "top": 1370, "height": 44, "left": 159}, "words": "们随机比较试验,通过与已有治疗方法的比较来判断盐酸多柔比星脂质体对试者的有效"}, {"probability": {"variance": 0.014763, "average": 0.950499, "min": 0.492493}, "location": {"width": 576, "top": 1422, "height": 32, "left": 159}, "words": "门评价患有中至重度卡波氏肉瘤病人的用药安全性和耐受性"}, {"probability": {"variance": 0.002959, "average": 0.976694, "min": 0.697861}, "location": {"width": 786, "top": 1469, "height": 36, "left": 206}, "words": "共有241例中至重度卡波氏肉瘤病人参加,其中218例可用于疗效的评价。盐酸多柔"}, {"probability": {"variance": 0.016737, "average": 0.909101, "min": 0.460815}, "location": {"width": 832, "top": 1516, "height": 36, "left": 158}, "words": "比脂质体和BV(15mg/m3博莱莓紫利1.4mg/m2长春新碱)均为静脉给药,盐酸多柔比星"}, {"probability": {"variance": 0.020042, "average": 0.923958, "min": 0.507183}, "location": {"width": 607, "top": 1565, "height": 30, "left": 157}, "words": "脂质体每二给药次,剂量为20mg/m2,BV纽治疗周期为三周"}], "language": 3}